GO:0034021 response to silicon dioxide: Cellular Stress Response, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034021 (response to silicon dioxide) describes any process by which a cell or organism changes its state or activity in response to a silicon dioxide (silica) stimulus [1,5].
• Silicon dioxide exposure triggers dose-dependent inflammatory, fibrotic, and oxidative stress responses in lung and immune cells, with sex-specific differences observed in silicotic mice [1,5].
• Mesoporous silica nanoparticles (MSNs) are widely studied both as inducers of osteoimmune and antitumour immune responses and as drug delivery vehicles that exploit the response to silicon dioxide [2,4,7].
• Key genes and pathways implicated include inflammatory cytokines (TNF, IL-1β, IL-6), oxidative stress regulators (Nrf2, HO-1), and immune checkpoint modulators in the tumour microenvironment [5,6,7].
• CRISPR knockout, knock-in, and overexpression models are essential to dissect causal roles of candidate genes in silica-induced pathology and to validate MSN-based therapeutic strategies [4,6,8].
• Understanding GO:0034021 informs safety assessment of silica nanomaterials and development of immunotherapies and targeted drug delivery systems [2,3,4,6].
Description
Silicon dioxide (silica) is one of the most abundant compounds on Earth and is widely used in industrial, pharmaceutical, and nanotechnological applications. The Gene Ontology term GO:0034021, response to silicon dioxide, captures the full spectrum of cellular and organismal changes triggered by silica exposure, including alterations in gene expression, cytokine secretion, oxidative stress, and immune cell activation [1,5]. This term is critical for researchers studying environmental lung diseases such as silicosis, as well as for those developing silica-based nanomedicines and drug delivery systems [2,4,7]. The response to silicon dioxide is not a single linear pathway but a complex network involving pattern recognition receptors, inflammasome activation, and transcriptional reprogramming [5,7]. Sex differences in silicotic mice further highlight the importance of genetic and hormonal modifiers in shaping this response. As silica nanoparticles become increasingly prevalent in cancer immunotherapy and targeted drug delivery, a precise understanding of GO:0034021 is essential for predicting both therapeutic efficacy and potential toxicity [4,6,8]. This article integrates authoritative QuickGO annotation with verified PubMed literature to provide a research-grade overview of the genes, mechanisms, and experimental models associated with response to silicon dioxide.
response to silicon dioxide At A Glance
| GO ID | GO:0034021 |
|---|---|
| GO term | response to silicon dioxide |
| Ontology | biological_process |
| Synonym | response to silica; response to silox |
| Definition | Any process that results in a change in state or activity of a cell or an organism as a result of a silicon dioxide stimulus. |
| Major function | Mediates cellular and organismal responses to silica exposure, including inflammation, oxidative stress, and immune modulation. |
| Related stimuli | Silicon dioxide nanoparticles, crystalline silica, mesoporous silica. |
| Key cell types | Macrophages, lung epithelial cells, osteoimmune cells, tumour-associated immune cells. |
| Disease relevance | Silicosis, lung injury, cancer immunotherapy, osteoimmunomodulation. |
What Is GO:0034021?
According to the Gene Ontology, GO:0034021 (response to silicon dioxide) is defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a silicon dioxide stimulus. This biological process encompasses the detection of silica particles, signal transduction, and the downstream cellular and systemic reactions, including inflammatory cytokine production, oxidative stress responses, and tissue remodeling [1,5].
Why Is response to silicon dioxide Important in Cell Biology?
GO:0034021 is important because silicon dioxide is ubiquitous in the environment and increasingly used in biomedical nanotechnology. Dysregulated responses to silica underlie occupational lung diseases such as silicosis and contribute to chronic inflammation and fibrosis [1,5]. Conversely, controlled silica-induced immune activation is being harnessed for cancer immunotherapy and vaccine adjuvants [4,6]. Understanding the genetic and molecular basis of this response enables the development of safer nanomaterials and more effective immunotherapies.
• Silicosis and other pneumoconioses are driven by aberrant responses to crystalline silica.
• Silica nanoparticles enhance endotoxin-induced lung injury, highlighting their pro-inflammatory potential.
• Mesoporous silica nanoparticles modulate osteoimmune responses, relevant for bone regeneration and implantology.
• Silica-based nanocarriers are used for targeted drug delivery in cancer and inflammation [2,8].
• Ultrasmall silica nanoparticles can remodel immunosuppressive melanoma microenvironments and improve survival.
• CO2-responsive silica Janus nanoparticles enable switchable biocatalysis in Pickering emulsions.
• Sex differences in silicotic mice indicate hormonal and genetic modifiers of the response.
• The response to silicon dioxide intersects with oxidative stress, inflammasome, and NF-κB pathways [5,7].
• Understanding GO:0034021 aids in predicting nanomaterial toxicity and designing safe-by-design particles.
• CRISPR screening can identify novel regulators of silica-induced inflammation and fibrosis [4,6].
What Happens During response to silicon dioxide?
Recognition and Uptake of Silica Particles
In simple terms: Cells first detect and engulf silica particles, which triggers the response.
Macrophages and epithelial cells recognize silicon dioxide particles through scavenger receptors and pattern recognition receptors. Upon uptake, silica particles can disrupt lysosomal membranes and activate the NLRP3 inflammasome, leading to IL-1β maturation and secretion [5,7]. This initial recognition step is a key determinant of downstream inflammatory outcomes and is influenced by particle size, surface chemistry, and crystallinity.
Inflammatory Cytokine Production
In simple terms: The cell releases signals that call immune cells to the site, causing inflammation.
Following silica exposure, activated macrophages and epithelial cells produce pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β. In silicotic mice, sex differences in cytokine profiles have been observed, with male and female mice showing distinct inflammatory responses. Silica nanoparticles can also synergize with endotoxins to amplify lung injury through enhanced cytokine release.
Oxidative Stress and Antioxidant Response
In simple terms: Silica causes oxidative damage, and cells try to defend themselves with antioxidants.
Silicon dioxide particles induce reactive oxygen species (ROS) generation, leading to oxidative stress. Cells respond by activating the Nrf2/ARE pathway, upregulating antioxidant enzymes such as heme oxygenase-1 (HO-1) and NAD(P)H quinone dehydrogenase 1 (NQO1) [5,7]. This oxidative stress response is a critical component of GO:0034021 and contributes to silica-induced cytotoxicity and fibrosis.
Immune Cell Activation and Microenvironment Remodeling
In simple terms: Silica can wake up the immune system and change the neighbourhood around tumours or implants.
Mesoporous silica nanoparticles have been shown to modulate osteoimmune responses, affecting macrophage polarization and osteoclast/osteoblast balance. In cancer, ultrasmall core-shell silica nanoparticles can remodel suppressive melanoma microenvironments, enhancing antitumour immunity and survival in preclinical models. These effects are mediated through changes in cytokine profiles, immune cell recruitment, and checkpoint molecule expression.
Tissue Remodeling and Fibrosis
In simple terms: Long-term silica exposure can lead to scarring of the lungs or other tissues.
Chronic exposure to crystalline silica leads to fibroblast activation, collagen deposition, and fibrosis. In silicotic mice, sex-specific differences in fibrosis markers and inflammatory gene expression have been reported. The response to silicon dioxide thus includes not only acute inflammation but also long-term tissue remodeling processes driven by persistent silica particles.
Key Genes Involved in GO:0034021 response to silicon dioxide
The following genes and proteins are key players in the cellular response to silicon dioxide, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TNF | Pro-inflammatory cytokine secreted by macrophages upon silica exposure | Mediates acute lung inflammation and silicosis [1,5] |
| IL1B | Inflammasome-dependent cytokine driving neutrophilic inflammation | Central to silica-induced lung injury |
| IL6 | Cytokine involved in acute phase response and fibrosis | Marker of silica-induced inflammation [1,5] |
| NLRP3 | Inflammasome sensor activated by silica particles | Key mediator of IL-1β release [5,7] |
| NFKB1 | Transcription factor regulating inflammatory gene expression | Controls cytokine production in response to silica |
| NFE2L2 | Master regulator of antioxidant response (Nrf2) | Protects against silica-induced oxidative stress [5,7] |
| HMOX1 | Antioxidant enzyme upregulated by Nrf2 | Marker of oxidative stress response |
| NQO1 | Detoxifying enzyme induced by Nrf2 | Contributes to cellular defense against silica |
| MAPK1 | Kinase in MAPK signaling cascade | Mediates silica-induced cytokine production |
| MAPK3 | Kinase in MAPK signaling cascade | Mediates silica-induced cytokine production |
| AKT1 | Survival kinase activated by silica exposure | Regulates cell survival and inflammation |
| PIK3CA | Catalytic subunit of PI3K | Involved in silica-induced signaling |
| CASP1 | Inflammasome caspase activating IL-1β | Essential for silica-induced IL-1β maturation |
| PYCARD | Adaptor protein for NLRP3 inflammasome | Required for inflammasome assembly |
| CD274 | Immune checkpoint ligand PD-L1 | Modulated by silica nanoparticles in tumour immunity |
| PDCD1 | Immune checkpoint receptor PD-1 | Target of silica-based immunotherapy |
| CTLA4 | Immune checkpoint receptor | Potential modulator in silica nanoparticle immunotherapy |
How Is response to silicon dioxide Regulated?
The response to silicon dioxide is regulated at multiple levels. At the transcriptional level, NF-κB and AP-1 control the expression of pro-inflammatory cytokines such as TNF, IL-6, and IL-1β. The Nrf2/ARE pathway regulates antioxidant genes including HMOX1 and NQO1, providing negative feedback on oxidative stress [5,7]. Inflammasome activation is tightly controlled by NLRP3, PYCARD, and CASP1, and dysregulation leads to excessive IL-1β production. Additionally, sex hormones and genetic background modulate the intensity of the response, as evidenced by sex differences in silicotic mice. Mesoporous silica nanoparticle surface properties can also influence immune cell polarization and osteoimmune responses.
response to silicon dioxide and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TNF | Silicosis, lung inflammation | TNF knockout mice exposed to silica [1,5] |
| IL1B | Silicosis, inflammasome activation | IL-1β knockout or NLRP3 knockout mice |
| NFE2L2 | Oxidative stress, silicosis | Nrf2 knockout mice [5,7] |
| CD274 | Melanoma immunotherapy | PD-L1 knockout tumour models with silica nanoparticles |
| HMOX1 | Antioxidant defense, lung injury | HO-1 knockout or overexpression models |
Silicosis and Occupational Lung Disease
Silicosis is a fibrotic lung disease caused by inhalation of crystalline silica. The response to silicon dioxide (GO:0034021) is central to disease pathogenesis, with macrophages and epithelial cells releasing pro-inflammatory cytokines and ROS that drive fibroblast activation and collagen deposition [1,5]. Sex differences in silicotic mice suggest that hormonal and genetic factors modify disease severity.
Cancer Immunotherapy and Tumour Microenvironment
Silica-based nanoparticles are being developed as immunotherapeutics. Ultrasmall core-shell silica nanoparticles can remodel suppressive melanoma microenvironments, enhancing antitumour immunity and improving survival in preclinical models. Mesoporous silica nanoparticles are also explored for cancer immunotherapy, leveraging the response to silicon dioxide to activate immune cells.
Osteoimmunology and Bone Regeneration
Mesoporous silica nanoparticles modulate osteoimmune responses, affecting macrophage polarization and bone cell activity. This has implications for bone regeneration and implant integration, where the response to silicon dioxide can be either beneficial or detrimental depending on particle properties.
Drug Delivery and Nanomedicine
Silica nanoparticles are widely used as drug delivery vehicles. Zinc oxide end-capped Fe3O4@mSiO2 core-shell nanocarriers enable targeted and responsive drug release for chemo-/ions synergistic therapeutics. pH-responsive oxygen self-sufficient nanoplatforms incorporating silica enhance tumour chemotherapy and photodynamic therapy. Understanding the biological response to these particles is essential for safety and efficacy.
From response to silicon dioxide-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X mediate silica-induced inflammation? | CRISPR knockout of gene X in macrophages or mice, followed by silica exposure |
| Does a point mutation in gene Y alter silica response? | CRISPR knock-in of specific point mutation in cell lines or mice |
| Can overexpression of gene Z protect against silicosis? | CRISPRa or lentiviral overexpression in lung epithelial cells |
| What is the role of gene W in silica nanoparticle-based immunotherapy? | Knockout mice or syngeneic tumour models with silica nanoparticles |
| How does sex influence silica response? | Male and female mice with targeted gene knockouts |
| Can silica nanoparticles deliver CRISPR components? | Mesoporous silica nanoparticles loaded with CRISPR ribonucleoproteins |
How to Study the response to silicon dioxide Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify pathways activated by silica exposure [1,6] |
| Proteomics | Protein abundance and modifications | Quantify inflammatory mediators [5,7] |
| Cytokine multiplex assay | Secreted cytokine levels | Assess inflammation in lung injury models |
| Histopathology | Tissue architecture and fibrosis | Evaluate silicosis severity |
| Confocal microscopy | Cellular uptake and localization of silica | Study nanoparticle internalization |
| CRISPR knockout screening | Gene function loss-of-function | Discover regulators of silica response |
| CRISPR activation screening | Gene overexpression | Identify protective genes |
| Flow cytometry | Immune cell populations and activation markers | Analyze tumour microenvironment remodeling |
Transcriptomic Profiling (RNA-seq)
RNA sequencing of cells or tissues exposed to silicon dioxide reveals global changes in gene expression, including inflammatory and antioxidant pathways. This method has been used to identify sex-specific differences in silicotic mice and to characterize immune responses to silica nanoparticles.
Proteomics and Cytokine Profiling
Mass spectrometry-based proteomics and multiplex cytokine assays quantify protein-level changes in response to silica. These approaches have been applied to study inflammatory mediators in lung injury models and to assess immune modulation by mesoporous silica nanoparticles.
Imaging and Histopathology
Confocal microscopy, electron microscopy, and histochemical staining visualize silica particle uptake, cellular localization, and tissue remodeling. These methods are essential for assessing fibrosis and immune cell infiltration in silicosis models [1,5].
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout or activation screens can identify novel regulators of the response to silicon dioxide. Such screens are particularly useful for discovering genes that modulate silica-induced inflammation, oxidative stress, or immune activation [4,6].
How CRISPR Can Be Used to Study GO:0034021 response to silicon dioxide
Knockout
CRISPR knockout of candidate genes such as TNF, IL1B, or NLRP3 in macrophages or mice allows researchers to test their causal role in silica-induced inflammation and fibrosis. For example, NLRP3 knockout reduces IL-1β production upon silica exposure. Knockout models are also valuable for validating targets identified in CRISPR screens.
Point Mutation
CRISPR knock-in of disease-associated point mutations can model genetic susceptibility to silicosis or modify silica nanoparticle interactions. For instance, mutations in antioxidant response elements or inflammasome components can be introduced to study their impact on the response to silicon dioxide [4,5].
Knock-in
Knock-in of reporter genes (e.g., fluorescent tags) or human orthologs enables tracking of silica-induced signaling in real time. Tagged knock-in models for NF-κB or Nrf2 can reveal dynamics of pathway activation in live cells or animals [5,7].
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of protective genes such as NFE2L2 or HMOX1 can test whether enhancing antioxidant defense mitigates silica toxicity. Overexpression models are also used to study silica nanoparticle-based drug delivery and immunotherapy [4,6].
How EDITGENE Supports response to silicon dioxide Research
Researchers studying response to silicon dioxide-related genes often need to determine whether a candidate gene is causally involved in silica-induced inflammation, oxidative stress, or immune modulation. EDITGENE provides comprehensive CRISPR gene editing services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for response to silicon dioxide research.
Frequently Asked Questions About response to silicon dioxide
What is GO:0034021 response to silicon dioxide?
GO:0034021 is a Gene Ontology biological process term defined as any process that results in a change in state or activity of a cell or an organism as a result of a silicon dioxide stimulus [1,5].
What genes are involved in response to silicon dioxide?
Key genes include TNF, IL1B, IL6, NLRP3, NFE2L2, HMOX1, and CD274, among others, as identified in silicosis and nanoparticle studies [1,5,6,7].
How does silica cause lung inflammation?
Silica particles activate the NLRP3 inflammasome and NF-κB pathway, leading to release of pro-inflammatory cytokines such as IL-1β and TNF-α [5,7].
What are the symptoms of silicosis?
Silicosis is characterized by progressive fibrosis and inflammation in the lungs, often with sex-specific differences in severity.
Can silica nanoparticles be used for cancer immunotherapy?
Yes, ultrasmall core-shell silica nanoparticles have been shown to remodel suppressive melanoma microenvironments and improve survival in preclinical models.
What is the role of Nrf2 in silica response?
Nrf2 (NFE2L2) regulates antioxidant genes such as HMOX1 and NQO1, protecting cells against silica-induced oxidative stress [5,7].
How do mesoporous silica nanoparticles modulate immune responses?
They can affect macrophage polarization and osteoimmune responses, influencing bone regeneration and inflammation.
What experimental models are used to study response to silicon dioxide?
Common models include knockout mice, cell lines exposed to silica, and CRISPR screens, as well as nanoparticle-based delivery systems [1,4,5].
Are there sex differences in silicosis?
Yes, studies in silicotic mice have revealed sex-specific differences in inflammatory gene expression and fibrosis.
How can CRISPR help study response to silicon dioxide?
CRISPR knockout, knock-in, and activation screens enable functional dissection of genes involved in silica-induced inflammation, oxidative stress, and immune modulation [4,6].
Conclusion
GO:0034021 (response to silicon dioxide) encompasses a complex network of cellular and organismal reactions to silica exposure, with critical implications for occupational lung diseases, cancer immunotherapy, and nanomedicine. The integration of QuickGO annotation with verified PubMed literature highlights key genes such as TNF, IL1B, NLRP3, and NFE2L2, and underscores the importance of sex-specific and context-dependent responses [1,5,7]. Advances in CRISPR gene editing and functional genomics are accelerating the discovery of novel regulators and therapeutic targets within this pathway [4,6]. As silica-based nanomaterials continue to be developed for drug delivery and immunotherapy, a precise understanding of GO:0034021 will be essential for ensuring safety and efficacy [2,8].
References
- 1. Jin F et al.. 2022. Effect of Sex Differences in Silicotic Mice.. Int J Mol Sci 23(22) PMID: 36430681
- 2. Liu M et al.. 2019. Zinc oxide end-capped Fe(3)O(4)@mSiO(2) core-shell nanocarriers as targeted and responsive drug delivery system for chemo-/ions synergistic therapeutics.. Drug Deliv 26(1):732-743 PMID: 31340678
- 3. Wang W et al.. 2024. Switchable CO(2)-Responsive Janus Nanoparticle for Lipase Catalysis in Pickering Emulsion.. J Agric Food Chem 72(17):9967-9973 PMID: 38639643
- 4. Liu J et al.. 2025. Bioactive mesoporous silica materials-assisted cancer immunotherapy.. Biomaterials 315:122919 PMID: 39481339
- 5. Ko JW et al.. 2018. Silicon Dioxide Nanoparticles Enhance Endotoxin-Induced Lung Injury in Mice.. Molecules 23(9) PMID: 30177658
- 6. De Leon G et al.. 2026. An ultrasmall core-shell silica nanoparticle improves antitumour immunity and survival by remodelling suppressive melanoma microenvironments.. Nat Nanotechnol 21(2):311-322 PMID: 41461940
- 7. Hosseinpour S et al.. 2022. Modulating Osteoimmune Responses by Mesoporous Silica Nanoparticles.. ACS Biomater Sci Eng 8(10):4110-4122 PMID: 34775744
- 8. Liu X et al.. 2024. pH-responsive oxygen self-sufficient smart nanoplatform for enhanced tumor chemotherapy and photodynamic therapy.. J Colloid Interface Sci 675:1080-1090 PMID: 39018635
